This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sher, E. S. Articles by Berkovitz, G. D. Search for Related Content PubMed PubMed Citation Articles by Sher, E. S. Articles by Berkovitz, G. D. Social Bookmarking                   What's this?

Evaluation of Boys with Marked Breast Development at Puberty

Claude J. Migeon, MD

Division of Pediatric Endocrinology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Gary D. Berkovitz, MD

CMSC 3-110, The Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, Maryland 21287-3311; Division of Pediatric Endocrinology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland

During the 10-year period from 1979 to 1988 we evaluated 60 boys who were more than 9 years old and who had significant breast development (greater than 4 cm in diameter) around the time of puberty. An endocrine abnormality was identified in seven subjects. The pathology included Klinefelter's syndrome; 46, XX maleness; primary testicular failure; partial androgen insensitivity; fibrolamellar hepatocarcinoma; and increased aromatase activity. Eight of the remaining 53 subjects had underlying medical problems, five of them having neurologic disorders. The 45 remaining subjects were considered to have significant idiopathic gynecomastia, a condition sometimes referred to as macromastia. These boys tended to be both taller and heavier than average, the mean Z score for height being 1.4 SDs above the mean and the mean weight score being 2.7 SDs above the mean. This study underscores the observation that pathologic causes of marked pubertal gynecomastia are unusual. However, the potential for significant health problems among boys with marked breast development supports the need for an endocrine evaluation of all affected subjects. Our data also indicate that boys with marked idiopathic breast development have greater body mass than other boys of similar age. This may contribute in part to the greater breast development in these subjects.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Paris, N. Servant, B. Terouanne, P. Balaguer, J. C. Nicolas, and C. Sultan A New Recombinant Cell Bioassay for Ultrasensitive Determination of Serum Estrogenic Bioactivity in Children J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 791 - 797. [Abstract] [Full Text] [PDF]